Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Cure Health Inc. (MCUR.CN)

Mind Cure Health Inc. (MCUR.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 38,446
  • Shares Outstanding, K 92,640
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MCUR.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings -0.05 on 02/28/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.390 +3.85%
on 08/03/21
0.470 -13.83%
on 07/16/21
-0.035 (-7.95%)
since 07/02/21
3-Month
0.310 +30.65%
on 05/18/21
0.490 -17.35%
on 06/22/21
+0.005 (+1.25%)
since 05/03/21

Most Recent Stories

More News
MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

COMTEX_390490679/2669/2021-07-27T03:30:28

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company's First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound

COMTEX_389720635/2669/2021-07-13T03:30:29

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Adopts Advance Notice Policy

/PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce that...

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
Maxim Group Initiates Coverage of Mind Cure Health

COMTEX_389138717/2669/2021-06-30T03:30:30

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression

COMTEX_388414578/2669/2021-06-17T03:30:28

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

COMTEX_387786784/2669/2021-06-03T10:04:31

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
This is Why Psilocybin May be Able to Help Millions with Mental Health Issue

Psychedelics could offer help for millions suffering from depression. In fact, according to the Washington ...

FTRPF : 5.7460 (-2.32%)
WESA.CN : 3.130 (+4.33%)
DBDID : 2.2000 (-4.76%)
RVV.CN : 0.500 (+2.04%)
RVVTF : 0.4000 (-1.72%)
MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
FTRP.CN : 5.550 (+1.46%)
MYND.CN : 0.750 (+7.14%)
Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer

COMTEX_386934898/2669/2021-05-20T03:30:28

LLY : 255.99 (+3.81%)
MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children's Hospital, as Company Advisor

COMTEX_386870536/2669/2021-05-19T03:30:29

MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM's Market Launch, Delivering Mental Wealth

MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM's Market Launch, Delivering Mental Wealth

LCDX : 0.3325 (-2.21%)
MCUR.CN : 0.405 (-2.41%)
MCURF : 0.3191 (-8.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.425
2nd Resistance Point 0.415
1st Resistance Point 0.410
Last Price 0.405
1st Support Level 0.395
2nd Support Level 0.385
3rd Support Level 0.380

See More

52-Week High 1.090
Fibonacci 61.8% 0.792
Fibonacci 50% 0.700
Fibonacci 38.2% 0.608
Last Price 0.405
52-Week Low 0.310

See More

Business Summary

Mind Cure Health Inc is a mental health and wellness company. The company is focused on the development, manufacture, and distribution of a branded line of organic, functional mushroom extracts. Its products are marketed under the Moonbeam Brand.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar